CA1338496C - Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques - Google Patents

Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques

Info

Publication number
CA1338496C
CA1338496C CA000524044A CA524044A CA1338496C CA 1338496 C CA1338496 C CA 1338496C CA 000524044 A CA000524044 A CA 000524044A CA 524044 A CA524044 A CA 524044A CA 1338496 C CA1338496 C CA 1338496C
Authority
CA
Canada
Prior art keywords
complex
hydroxy
pyrone
iron
hydroxypyrone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000524044A
Other languages
English (en)
Inventor
Robert Charles Hider
Michael Arthur Stockham
George Kontoghiorghes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB08327612A priority Critical patent/GB2128998B/en
Priority to EP83306246A priority patent/EP0107458B1/fr
Priority to US06/542,976 priority patent/US4575502A/en
Priority to DK4853/83A priority patent/DK485383D0/da
Priority to JP58198191A priority patent/JPS5993071A/ja
Priority to CA000446932A priority patent/CA1243606A/fr
Priority claimed from CA000446932A external-priority patent/CA1243606A/fr
Priority to AU24552/84A priority patent/AU567915B2/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Priority to CA000524044A priority patent/CA1338496C/fr
Priority to US07/054,086 priority patent/US4834983A/en
Priority to US07/073,330 priority patent/US4861767A/en
Priority to HK160/90A priority patent/HK16090A/xx
Priority to JP2266179A priority patent/JPH03223274A/ja
Publication of CA1338496C publication Critical patent/CA1338496C/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000524044A 1982-10-22 1986-11-28 Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques Expired - Fee Related CA1338496C (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB08327612A GB2128998B (en) 1982-10-22 1983-10-14 Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
EP83306246A EP0107458B1 (fr) 1982-10-22 1983-10-14 Compositions pharmaceutiques
US06/542,976 US4575502A (en) 1982-10-22 1983-10-18 Pharmaceutical compositions
DK4853/83A DK485383D0 (da) 1982-10-22 1983-10-21 Fremgangsmade til fremstilling af jernkomplekser
JP58198191A JPS5993071A (ja) 1982-10-22 1983-10-22 薬剤組成物
CA000446932A CA1243606A (fr) 1982-10-22 1984-02-07 Compositions pharmaceutiques renfermant des complexes de fer de 3-hydroxy-4-pyrones
AU24552/84A AU567915B2 (en) 1982-10-22 1984-02-09 Pharmaceutical compositions containing iron complexes of 3-hydroxy-4-pyrones
CA000524044A CA1338496C (fr) 1982-10-22 1986-11-28 Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques
US07/054,086 US4834983A (en) 1982-10-22 1987-05-26 Pharmaceutical compositions
US07/073,330 US4861767A (en) 1982-10-22 1987-07-13 Pharmaceutical compositions
HK160/90A HK16090A (en) 1982-10-22 1990-03-01 Pharmaceutical compositions
JP2266179A JPH03223274A (ja) 1982-10-22 1990-10-02 ３―ヒドロキシ―４―ピロン錯体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8230150 1982-10-22
CA000446932A CA1243606A (fr) 1982-10-22 1984-02-07 Compositions pharmaceutiques renfermant des complexes de fer de 3-hydroxy-4-pyrones
CA000524044A CA1338496C (fr) 1982-10-22 1986-11-28 Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000446932A Division CA1243606A (fr) 1982-10-22 1984-02-07 Compositions pharmaceutiques renfermant des complexes de fer de 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
CA1338496C true CA1338496C (fr) 1996-07-30

Family

ID=25670286

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000524044A Expired - Fee Related CA1338496C (fr) 1982-10-22 1986-11-28 Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques

Country Status (1)

Country Link
CA (1) CA1338496C (fr)

Similar Documents

Publication Publication Date Title
CA1243606A (fr) Compositions pharmaceutiques renfermant des complexes de fer de 3-hydroxy-4-pyrones
CA1253803A (fr) Composes pour administration orale ou nasale contenant des complexes de 3-hydroxy-4-pyrones
US6004951A (en) Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
EP0138420B1 (fr) Compositions pharmaceutiques contenant des dérivés de 1-hydroxypyrid-2-one
US4666927A (en) Pharmaceutical compositions of hydroxypyridones
US5258376A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US4894455A (en) Pharmaceutically active zinc complexes
US5574027A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5177068A (en) Pharmaceutical compositions
CA1286844C (fr) Compositions pharmaceutiques
US4550101A (en) Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia
GB2117766A (en) Pharmaceutical compositions
USRE37534E1 (en) Pharmaceutical compositions
CA1338496C (fr) Complexes de fer et de 3-hydroxy-4-pyrones, possedant des proprietes pharmaceutiques
EP0612246B1 (fr) Compositions pharmaceutiques comprenant des complexes au gallium de 3-hydroxy-4-pyrones
WO1991017751A1 (fr) Compositions de gallium administrables par voie orale et procedes de traitement les utilisant
NZ207045A (en) Iron complexes of pyrone derivatives and pharmaceutical compositions
IE57000B1 (en) Pharmaceutical compositions
AU1359492A (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
DK162420B (da) Ferrikomplekser til medicinsk anvendelse, farmaceutiske praeparater indeholdende disse, samt fremstilling af bladninger til brug i praeparaterne

Legal Events

Date Code Title Description
MKLA Lapsed